Expert Analysis

How To Engage With Gov't's Direct-To-Consumer Drug Policy

The U.S. Department of Health and Human Services' recent request for industry input on manufacturers' direct-to-co... (more story)

When Fraud Involvement Disqualifies FCA Whistleblowers

A Massachusetts federal court's recent dismissal of a False Claims Act relator in U.S. ex rel. Perry v. First Psyc... (more story)

Lessons From Justices' Split On Major Questions Doctrine

The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Power... (more story)

Deals & Corporate Governance More

Epilepsy Drugmaker's Statements Insulated From Stock Suit

A Pennsylvania federal judge has trimmed a shareholder class action against Marinus Pharmaceuticals alleging it misled investors about the probability of success of an epilepsy drug, ruling that certain statem... (more story)

Insulin Makers Ask Justices To Review Collusion Case

Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP have told the U.S. Supreme Court that a ruling reviving a case over insulin drug costs undermines key rules meant to wee... (more story)

Biomedical Co. Settles Trade Secrets Case Against Ex-Worker

Biomedical company Skye Orthobiologics and a former employee have informed a California federal judge that they have settled a case accusing the ex-employee of breaching fiduciary duties by leveraging Skye's p... (more story)

Justices Advised To Keep Law Clear In 'Skinny Label' Case

Several intellectual property groups have urged the U.S. Supreme Court to use a case involving "skinny labels" on generic drugs to set clear guidelines on what constitutes induced patent infringement, saying t... (more story)

Biopharma Brass Hid Drug Trial Risks, Derivative Suit Says

Brass of Ultragenyx Pharmaceutical Inc. are facing shareholder derivative claims they caused the company to overstate prospects for a drug to treat a bone disease, hurting investors and opening the company up ... (more story)

Actelion Pays $65M To Settle Tracleer Antitrust Class Suit

Actelion Pharmaceuticals Ltd. agreed to pay $65 million to resolve antitrust claims from a certified class accusing it of illegally denying generics companies the samples they need to produce generic versions ... (more story)

Digital Health & Technology More

DNA Testing Co. Can't Shake Suit Over Genetic Data Sharing

A Massachusetts federal judge refused to release Nebula Genomics Inc. from a proposed class action accusing it of illegally sharing its customers' genetic information with Meta and other third parties through ... (more story)

Fla. Judge Finds Leapfrog's Hospital Ratings Deceptive, Unfair

A Florida federal judge ordered hospital ratings nonprofit Leapfrog to revoke poor safety grades it issued to five hospitals owned by Tenet Healthcare Corp., finding the group's approach to evaluating the hosp... (more story)

Abortion Rights Group, SD Agree to End Gas Station Ads Row

An abortion rights group can no longer post advertisements at gas stations in South Dakota that promote abortion care, the South Dakota attorney general's office announced on Monday, saying that the group and ... (more story)

Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together

Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the telehealth p... (more story)

NC Providers Sue UnitedHealth Over 'Devastating' Cyberattack

UnitedHealth Group Inc. and several of its subsidiaries are facing a proposed class action in North Carolina state court over a 2024 data breach that took its claims processing platform offline and allegedly d... (more story)

TriZetto, Cognizant Hit With Class Claims Over Data Breach

A Cognizant Technology Solutions-owned healthcare tech company was hit with a proposed class action in New Jersey federal court on Friday over its alleged failure to protect the sensitive personal and health i... (more story)

Policy & Compliance More

Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar

Sandoz Inc. is appealing after a Virginia federal court ruled it should have brought claims accusing Amgen of blocking competition for the Enbrel biosimilar in a previous patent dispute, according to a Friday notice. 

Texas Justices Clear Way For AG Trans Care Probe

An LGBTQ+ advocacy organization must produce documents as part of an investigation from the Texas attorney general's office into transgender treatments for minors, the Texas Supreme Court ruled on Friday, sayi... (more story)

EPA Aims To Lift Biden-Era Ethylene Oxide Limits

The U.S. Environmental Protection Agency on Friday proposed rolling back limits on emissions of ethylene oxide, a carcinogenic chemical used in the sterilization of medical devices.

Ariz. Docs Ink $4.75M FCA Deal Over Unnecessary Treatment

An Arizona-based physician group that offers cardiology and vascular services has inked a $4.75 million settlement to resolve False Claims Act allegations they performed unnecessary vein ablations and submitte... (more story)

Top Texas Court Upholds Death Sentence For ICU Nurse

The Texas Court of Criminal Appeals on Thursday affirmed the death sentence of a former cardiovascular nurse convicted of intentionally murdering patients recovering from operations, finding that Texas prosecu... (more story)

Wash. Justices OK Jury Instruction In TB Malpractice Case

The Washington State Supreme Court declined Thursday to flip a family's loss in a case blaming an Evergreen State doctor for failing to address signs of an intestinal tuberculosis infection that led to a patie... (more story)